Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Multiple Sclerosis Journal Cover 201402
News Briefs | 11 Feb 2014

3-Year Average Delay in Identifying SPMS Transition

Diagnostic uncertainty regarding the transition from RRMS to SPMS may last about 3 years, with the delay potentially affecting not only patient care but also research

Laurie Barclay, M.D.
Diagnostic uncertainty regarding the transition from relapsing-remitting multiple sclerosis to secondary progressive MS may last about...
Clinical Research
Research Roundup logo
News Briefs | 7 Feb 2014

MS Research Roundup: February 7, 2014

Latest Myelin-Repair Candidate; Crowdsourcing Clinical Trials; Fingolimod Pregnancy Caution; Japan Neuroimmunology Meeting News

Carol Cruzan Morton
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Meetings, Methods
Research Roundup logo
News Briefs | 5 Feb 2014

MS Research Roundup: February 5, 2014

Clinical Trial Data Open to Scientists; Innate Immunity in Progressive MS; Paying for MS Drugs

Carol Cruzan Morton
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research
Metabolomics Fig 1a
News Briefs | 4 Feb 2014

CSF Metabolite Analysis May Offer Sensitive Biomarkers for MS

The systematic study of the complement of small-molecule metabolites in the CSF suggests altered energy and phospholipid metabolism in MS and may yield quantitative biomarkers

Laurie Barclay, M.D.
Systematic study of the complement of small molecule metabolites, known as metabolomics, suggests...
Laboratory Research
Teriflunomide
News Briefs | 3 Feb 2014

Teriflunomide Gets High Marks in Yet Another Phase 3 Trial

This placebo-controlled phase 3 study of oral teriflunomide for patients with relapsing MS concluded, as have previous studies, that the disease-modifying agent is safe and efficacious

Steven Fox
Evidence continues to accumulate that the disease-modifying agent teriflunomide may be a good option for...
Clinical Research
XX-XY
News Briefs | 3 Feb 2014

Sex Differences in MS Are Genetic, Not Just Hormonal

In contrast to their influence on immune system reactivity, female chromosomes confer protection to the central nervous system

Stephani Sutherland, Ph.D.
When it comes to sex differences, multiple sclerosis presents a paradox: Although women are more likely to...
Laboratory Research
Research Roundup logo
News Briefs | 31 Jan 2014

MS Research Roundup: January 31, 2014

New Molecule for Myelin Repair in Mice; Synapses Under Fire; New Dose for Copaxone; Mind-Altering Microbes

Carol Cruzan Morton
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research
Research Roundup logo
News Briefs | 29 Jan 2014

MS Research Roundup: January 29, 2014

B Cells for MS Diagnosis; More Research Needed on Laquinimod for European Regulators; Update on Toxin Trigger; New Way to Distribute Public Research Funds

Carol Cruzan Morton
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People
Brain journal cover
News Briefs | 28 Jan 2014

'Strikingly' Lower Familial Risk of MS Seen

This population-based study of more than 28,000 Swedish citizens with multiple sclerosis found strikingly lower ratios of familial recurrence of the disease compared with most previous studies

Steven Fox
A new population-based study of people with multiple sclerosis has found what the authors term...
Clinical Research

Pages